(Q43927646)

28 November 2017

title

Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models (English)

1 reference

28 November 2017

1 reference

Michael W Kattan

4

0 references

author name string

Nicholas F Marko

1

1 reference

28 November 2017

Zhiyuan Xu

2

1 reference

28 November 2017

Tianming Gao

3

1 reference

28 November 2017

Robert J Weil

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

16 December 2011

1 reference

28 November 2017

1 reference

28 November 2017

volume

118

1 reference

28 November 2017

issue

15

1 reference

28 November 2017

page(s)

3749-3757

1 reference

Global cancer statistics, 2002

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

CNS metastases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Metastatic behavior of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

An overview of prognostic factors for long-term survivors of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Breast cancer incidence and mortality trends in 16 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

How to build and interpret a nomogram for cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

7 January 2021

Are nomograms better than currently available stage groupings for bladder cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

7 January 2021

A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

7 January 2021

A nomogram predicting the probability of primary breast cancer survival at 2- and 5-years using pathological and biological tumor parameters

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

7 January 2021

Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26716

7 January 2021

Identifiers

DOI

10.1002/CNCR.26716

1 reference

28 November 2017

1 reference